As part of the deal, the company will be watched by an independent compliance monitor. Biomet is paying a $17.2 million penalty and must give up nearly $5.6 million in profits. In exchange, the DOJ won’t prosecute Biomet for improper payments related to the case.
In a podcast with Molly Blake-Michaels, Senior Director of Clinical Services for ClearTrial, find out how to plan, forecast, and track medical device clinical trials, along with the concepts that can be employed to help overcome them.
If you’re in New England, I recommend stopping by Brown University on Thursday, March 29 for the "Materials by Design" conference. Speakers hail from Medtronic, GM, MIT, Brown University, and other well-respected institutions.